SB 731 amends the existing Pharmaceutical Assistance Contract for the Elderly (PACE) program to add a new "Needs Enhancement Tier" for determining eligibility. This tier would allow more elderly residents to qualify for prescription drug assistance based on specific financial or health needs. The bill changes how eligibility is assessed under the program, making it easier for seniors with higher needs to access medication support. The bill recently passed final passage on November 12, 2025, and is now referred to Rules & Executive Nominations.
HB 923 amends the State Lottery Law to redirect lottery revenue toward providing pharmaceutical assistance for elderly residents. It directly affects seniors who qualify for prescription drug aid under state programs by modifying eligibility determination procedures. The key provision updates how income and asset thresholds are calculated to determine who qualifies for this assistance. The bill became law on November 24, 2025, after approval by both legislative chambers and the governor.
SB 95 amends Pennsylvania's Pharmacy Act to create a 180-day provisional license for pharmacists moving from other states, allowing them to practice without demonstrating competency under Pennsylvania's requirements. It also permits emergency medical services providers to distribute naloxone dose packages for opioid overdose reversal under specific conditions, including a Department of Health standing order and voluntary distribution without liability. Additionally, the bill requires pharmacies to disclose prescription drug prices (brand vs. generic), cost-sharing amounts, and health insurance options upon customer request. These changes aim to improve pharmacist mobility, expand naloxone access, and increase price transparency for consumers.
SB 301 requires Pennsylvania pharmacies to disclose specific pricing information to consumers upon request for prescription medications. This includes the current retail price for brand-name and generic drugs, the consumer's cost-sharing amount under their insurance, and details about subsidized health coverage through Pennsylvania's health insurance exchange. Pharmacies must keep records of this information, post clear notices about the disclosure right, and present details in simple terms. Failure to comply results in a $500 fine per violation. The law applies to all retail pharmacies and directly affects consumers making prescription purchasing decisions.
HB 1881 updates Pennsylvania's Pharmacy Act to modernize requirements for pharmacy technicians and trainees, including new registration qualifications and supervision rules by licensed pharmacists. It adds specific protocols for pharmacies administering injectable medications, biologicals (like vaccines), and immunizations, while requiring detailed reports on vaccine administration. The bill also establishes new standards for clinical laboratory certificates and repeals outdated sections of the original 1961 law. These changes directly affect pharmacies, pharmacy technicians, trainees, and pharmacists who oversee vaccine and medication administration.
SB 1055 updates Pennsylvania's Pharmacy Act to modernize requirements for pharmacy technicians and trainees, including registration, qualifications, and supervision standards. It specifically adds provisions allowing pharmacy technicians to administer injectable medications, biologicals, and vaccines under pharmacist supervision, and requires pharmacies to report vaccine administration data. This directly affects pharmacy technicians, pharmacists, and patients receiving vaccines or medications in pharmacy settings. The bill aims to clarify roles and reporting for pharmacy-based vaccine services while maintaining pharmacist oversight.
SB 268 amends Pennsylvania's Insurance Company Law to establish rules for calculating health insurance cost-sharing. It requires insurers and pharmacy benefits managers (PBMs) to include all out-of-pocket payments made by insured individuals (or others on their behalf) when determining cost-sharing amounts like deductibles or copays. The law applies to health insurance policies issued, renewed, or entered into after its effective date, but excludes dental, vision, workers' compensation, and similar coverage types. This change directly affects health insurers, PBMs, and policyholders by standardizing how cost-sharing is calculated under health plans.
HB 305 requires health insurance policies to cover insulin, directly affecting people with diabetes who rely on this medication. It amends the 1921 Insurance Company Law to mandate that casualty insurance plans include insulin coverage without excessive cost-sharing. The key provision eliminates gaps where insulin might previously have been excluded or subject to high out-of-pocket costs. This policy change applies to all insurers offering casualty coverage under the amended law. The bill is currently pending before the Insurance committee.
HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
HB 1224 removes a citizenship requirement from Pennsylvania's pharmacist licensing rules. The bill amends the 1961 Pharmacy Act to delete the phrase "and is a citizen of the United States" from the eligibility criteria for pharmacists. This change directly affects individuals applying for pharmacist licenses in Pennsylvania who previously needed U.S. citizenship. The key provision modifies Section 3(a)(1) of the Pharmacy Act to allow licensure based solely on age (21+) and other existing requirements, without requiring U.S. citizenship. The bill takes effect 60 days after enactment.